Cough And Cold
Recalled products include Teething Drops, Nausea Drops, Intestinal Colic Drops, Stomach Calm, Expectorant Cough Syrup, Silver-Zinc Throat Spray, and Argentum Elixir.
The affected packages are being recalled because the ingredients on the front sticker may not match the actual product in the carton.
"This is the first multi-year, year-round study that includes detailed data on how consumers used acetaminophen medications," said Dr. Shiffman.
These products will no longer be indicated for use in children, and their use in this age group is not recommended.
A decline in immunoprophylaxis was associated with an increased risk of RSV hospitalization among infants 29-34 weeks gestational age who were <6 months of age for both commercial- and Medicaid-insured.
Specifically, this panel of independent experts will discuss the the benefits and risk associated with the use of these products in this patient population as well as current treatment practices.
Results, measured by a recording device, found that those in the 50mg MK-7264 group had a statistically significant reduction in cough frequency of 37% when compared with placebo.
At 48 hours, more patients receiving dexamethasone than placebo (35.4% vs 27.1%) had complete symptom resolution, which was also observed in patients not offered delayed antibiotics.
This case looks at the very important issue of drug information - specifically what should health care practitioners know about a medication before it is prescribed to a patient.
Study authors concluded that a "significant dose-response relationship" existed between the vitamin C dose and duration of the common cold.
To assess the efficacy of vitamin D in suppressing acute respiratory infections, researchers analyzed results from 25 randomized controlled trials which included over 11,000 participants.
Use of nonsteroidal anti-inflammatory drugs (NSAIDs) during acute respiratory infection may significantly increase the risk of heart attack, according to a new 7-year observational study.
Acella has received approval for a sugar-free bioequivalent to the antihistamine/decongestant Bromfed DM Cough Syrup (brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup, 2mg/30mg/10mg per 5mL).
Based on data from a comprehensive surveillance program of OTC cough/cold medicine, no deaths were reported in children aged <12 years after ingestion of single-ingredient dextromethorphan product.
There is some concern that some parents might not get their children vaccinated this season because only injectable flu vaccine is available.
The Mentholatum Company announced the launch of Mentholatum No Mess Vaporizing Rub with Roll On Applicator for use in children aged ≥2 years for the cough and cold season.
A clinical rule developed by researchers from the United Kingdom can help general practitioners and nurses in primary care distinguish children at very low, normal, and high risk of future hospital admission for respiratory tract infection (RTI).
Profounda announced the launch of Rhinase Soothing Nasal Gel and Rhinase Lubricating Nasal Mist for use in patients with nasal dryness associated with allergies, low humidity, stuffy nose, and nosebleeds.
Clemastine fumarate, an over-the-counter (OTC) antihistamine, was found to partially reverse vision damage in patients with multiple sclerosis (MS), according to a preliminary study that will be presented at the AAN 68th Annual Meeting.
Despite an increased proportion of Bordetella pertussis isolates lacking pertactin, vaccine effectiveness (VE) is still high in Vermont for the five-dose diphtheria, tetanus, and acellular pertussis vaccine (DTaP) series and the tetanus, diphtheria, and acellular pertussis vaccine (Tdap).
Perrigo and Allergan announced the launch of Guaifenesin Extended-Release Tablets, the generic version of Reckitt Benckiser's Mucinex Maximum Strength.
Omalizumab significantly lowered the number of colds in inner-city children with allergic asthma, findings from a study showed.
Pfizer Consumer Healthcare announced a voluntary recall of one lot of Adult Robitussin Peak Cold Cough + Chest Congestion DM due to some bottles being mislabeled as Adult Robitussin Maximum Strength Nighttime Cough DM
The Food and Drug Administration (FDA) is warning consumers to not use Licorice Coughing Liquid due to the presence of unidentified morphine.
Perrigo announced a voluntary recall to the retail level of 2 batches of its Children's Guaifenesin Grape Liquid (100mg per 5mL) and 3 batches of its Children's Guaifenesin DM Cherry Liquid (100mg/5mg per 5mL) supplied in 4oz bottles with dosage cups.